← All stocks

Moderna

MRNA Net selling
CIK 0001682852 #318 in the set updated 17 Sep 2026
Bought (120 mo)
$7.01M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$3.76B
$101.72M on a plan · $1.52B straight out of an exercise
Sold at will
$2.13B
998 of 2789 sales
Net
−$3.75B
−$2.13B against sales at will

By person

26 insiders · 2,803 transactions
1,362×

Stéphane Bancel holds 1,362 times base salary in stock. $2.29B of shares against $1.68M in salary for 2025.

Salary from the company's own proxy. The shares are what Stéphane Bancel last reported holding, valued at $146.07, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
AFEYAN NOUBAR
Director
$1.65B (317)
−$1.65B
2,227,939
0.5581%
$325.44M
Bancel Stephane
Chief Executive Officer
$5.00M (2)
$1.22B (1320) scheduled
−$1.21B
15,650,946
3.92%
$2.29B
+247.7%
Hoge Stephen
President
$324.22M (496) scheduled
−$324.22M
1,870,011
0.4684%
$273.15M
−17.3%
Andres Juan
See remarks
$229.88M (188) scheduled
−$229.88M
12,803
0.0032%
$1.87M
Zaks Tal Zvi
Chief Medical Officer
$114.15M (306) scheduled
−$114.15M
0
0.0000%
$0.00
−100.0%
Flagship Ventures Fund IV General Partner LLC entity
Director
$76.42M (22)
−$76.42M
0
0.0000%
$0.00
−100.0%
Kim Lorence H.
Chief Financial Officer
$71.54M (45) scheduled
−$71.54M
1,202,510
0.3012%
$175.65M
+4.9%
HENDERSON LORI M.
General Counsel and Secretary
$36.63M (32) scheduled
−$36.63M
901
0.0002%
$131.61K
0.0%
Kania Edwin
10% owner
$11.50M (3)
−$11.50M
23,847
0.0060%
$3.48M
−96.0%
NABEL ELIZABETH G
Director
$8.48M (2) scheduled
−$8.48M
19,317
0.0048%
$2.82M
−37.0%
HUTT PETER BARTON
Director
$5.80M (2) scheduled
−$5.80M
3,924
0.0010%
$573.18K
0.0%
Mock James M
Chief Financial Officer
$5.73M (14) scheduled
−$5.73M
59,375
0.0149%
$8.67M
Klinger Shannon Thyme
Chief Legal Officer
$3.48M (28) scheduled
−$3.48M
81,340
0.0204%
$11.88M
+7,221%
SAGAN PAUL
Director
$2.00M (2)
$708.53K (1)
+$1.30M
312,730
0.0783%
$45.68M
Nader Francois
Director
$434.98K (1) scheduled
−$434.98K
32,781
0.0082%
$4.79M
Garay Arpa
Chief Commercial Officer
$394.37K (3) scheduled
−$394.37K
3,690
0.0009%
$539.00K
+1,242%
Hussain Abbas
Director
$287.60K (3) scheduled
−$287.60K
12,066
0.0030%
$1.76M
Burton Paul
Chief Medical Officer
$190.57K (2)
−$190.57K
954
0.0002%
$139.35K
Meline David W
Chief Financial Officer
$147.69K (3)
−$147.69K
2,857
0.0007%
$417.32K
+67.3%
LEE JENNIFER LING
Chief Accounting Officer
$9.87K (1)
−$9.87K
4,419
0.0011%
$645.48K
LANGER ROBERT
Director
11,467,664
2.87%
$1.68B
0.0%
Berenson Stephen
Director
22,203
0.0056%
$3.24M
Horning Sandra
Director
18,585
0.0047%
$2.71M
Rubenstein David M.
Director
9,643
0.0024%
$1.41M
Tallett Elizabeth E
Director
4,761
0.0012%
$695.44K
Ruiz Israel
Director
4,559
0.0011%
$665.93K
Insider
Date
Role
Action
Shares
Price
Amount
Bancel Stephane
6 Aug 2026
Chief Executive Officer
Exercised, kept
252,469
$19.15
$4.83M
Bancel Stephane
11 Dec 2025
Chief Executive Officer
Exercised, kept
688,073
$10.90
$7.50M
Showing 250 of 2,803 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 1,016
Amendments (4/A) skipped 12
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 279
Sales straight out of an exercise 1,512
Sales at will 998
Transactions with no price 1
Shares from compensation/vesting 108,581,601
Sales filed before the plan box existed 994
History held since 13 Dec 2018